The controversial weight-loss drug Ozempic is a GLP-1
This waist circumference reduction is crucial because it indicates loss of visceral fat, the dangerous fat around your organs that contributes to metabolic disease
Any changes to GLP-1 dosing, including maintenance or micro-dosing, should be done under medical supervision to ensure safety, effectiveness, and personalized care.
However, the use of these medications is controversial because they are not approved by the U.S
For those who are postmenopausal and exploring GLP-1s, talk to a clinician about safe, personalized dosing or GLP-1 microdosing options
After reviewing clinical trial data, post-marketing surveillance reports, and real-world evidence across millions of prescriptions, the EMA concluded in 2024 that the available evidence does not support a causal association between GLP1 receptor agonists and suicidal or self-injurious behavior